Dr. Jeffrey A. Kahn, MD

Dr. Kahn practices at Keck Hospital of USC in Los Angeles, California, part of University of Southern California.

Dr. Kahn's NPI, 1639194822, was assigned on July 12, 2006. Dr. Kahn graduated from SUNY Upstate Medical University in 1991. Dr. Kahn holds California license G81319.

Dr. Kahn's primary practice is Keck Hospital of USC, at 1500 San Pablo Street, Los Angeles, CA 90033 in Los Angeles County. The practice phone is (323) 442-8656.

Dr. Kahn's primary practice is Keck Hospital of USC in Los Angeles, California, part of University of Southern California. Dr. Kahn is also affiliated with Los Angeles General Medical Center. The medical group on file is USC Care Medical Group. Dmand AI also links Dr. Kahn to 1 more hospital, 1 group practice or clinic, 1 other site and 1 urgent care center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kahn practices, 6 sites in all. Vendor and product names are available with a free account.

Transplant hepatology is Dr. Kahn's primary specialty in the NPI Registry, under taxonomy code 207RT0003X. Dr. Kahn is board certified in gastroenterology by the American Board of Internal Medicine. Dmand AI has Dr. Kahn's licenses on file in 5 states: California, Nevada, Arizona, Washington and Georgia.

Dmand AI lists cirrhosis, cirrhosis of the liver, colonoscopy, electrolyte disorders, fatty liver, gastrointestinal inflammation, hepatitis c and liver disease among the conditions Dr. Kahn treats.

CMS data shows 511 Medicare services from Dr. Kahn across 9 procedure codes in 2024, for 257 Medicare patients. Medicare paid $43,689 for them.

CMS counts 257 Medicare patients who saw Dr. Kahn in 2024. The largest group is 65 to 74, with 144 patients. 75% of them have high blood pressure, and 70% have high cholesterol. 51% are also on Medicaid. Their average risk score is 3.07, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kahn's median patient age at 64, with 47% women.

In 2024, Dr. Kahn wrote 1,413 Medicare Part D claims for 153 patients. 83% of them were for generic drugs. CMS names the drug for 1,233 of them, across 23 drugs with 11 or more claims each, at $519,213 in total drug cost. In 2023, CMS named 1,220 claims across 25 drugs.

Dr. Kahn accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Kahn as offering telehealth.

Dmand AI links 1 paper to Dr. Kahn. Dr. Kahn's most frequent co-author is Norah A. Terrault, MD.

CMS Open Payments shows 73 general payments to Dr. Kahn from 20 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 37% of the total. Mallinckrodt LLC paid the most, $6,912.

Dr. Kahn graduated from SUNY Upstate Medical University in 1991.

Dr. Kahn is in network with 11 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.